IDS Gene (Iduronate 2-Sulfatase)

Genetic and Functional Insights into IDS, the Gene Associated with Hunter Syndrome (MPS II)

Gene Information Card

Symbol IDS
Full Name Iduronate 2-Sulfatase
Gene Type Protein coding
Chromosomal Location Xq28
NCBI Gene ID 3423 ncbi.nlm.nih.gov/gene/3423
Ensembl ID ENSG00000010404
UniProt ID P22304
OMIM ID 300823
HGNC ID 5389
Aliases MPS2, SIDS, ID2S

Description

The IDS gene encodes iduronate 2-sulfatase, a lysosomal enzyme that catalyzes the hydrolysis of 2-sulfate groups from the glycosaminoglycans dermatan sulfate and heparan sulfate. This step is essential for the degradation of these molecules. Mutations in IDS cause mucopolysaccharidosis type II (Hunter syndrome), an X-linked recessive lysosomal storage disorder characterized by progressive accumulation of glycosaminoglycans in tissues, leading to multi-systemic involvement including skeletal abnormalities, organomegaly, neurological decline, and shortened lifespan.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Mucopolysaccharidosis type II (Hunter syndrome) Loss-of-function mutations in IDS lead to deficient iduronate 2-sulfatase activity, causing accumulation of dermatan and heparan sulfate in lysosomes. ClinVar, OMIM #309900
Mucopolysaccharidosis type II, attenuated form Partial enzyme activity due to missense mutations results in milder, later-onset phenotype with less neurological involvement. ClinVar, OMIM #309900

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.3 Medium
Kidney 9.8 Medium
Lung 7.5 Low
Brain 6.2 Low
Heart 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.5 Hepatocellular carcinoma cell line
A549 8.9 Lung carcinoma cell line
HEK 293 7.3 Embryonic kidney cell line
K-562 6.1 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1402C>T (p.Arg468Trp) Missense Common Reduced enzyme activity; associated with attenuated Hunter syndrome
c.1122C>T (p.Arg374Ter) Nonsense Frequent Premature stop; complete loss of function; severe phenotype
c.998C>T (p.Ser333Leu) Missense Recurrent Partial activity; attenuated form
c.1037T>C (p.Leu346Pro) Missense Rare Severe loss of function; early-onset disease
Mutation functional classification

Loss of Function (LOF)

Most IDS mutations result in loss of enzyme function, leading to substrate accumulation and Hunter syndrome. Nonsense, frameshift, and large deletions typically cause severe, early-onset disease.

Gain of Function (GOF)

No gain-of-function mutations have been reported for IDS.

Dominant Negative (DN)

No dominant-negative effects are described; IDS is X-linked and hemizygous males are fully affected.

Pathways

['Glycosaminoglycan degradation (KEGG: hsa00531)']
['Lysosome (KEGG: hsa04142)']
['Mucopolysaccharidosis (Reactome: R-HSA-1660662)']

Protein Summary

Iduronate 2-sulfatase (UniProt P22304) is a 550-amino-acid lysosomal enzyme synthesized as a precursor that undergoes post-translational processing, including glycosylation and proteolytic cleavage, to generate the mature active form. The enzyme requires calcium for activity and specifically removes 2-O-sulfate groups from iduronic acid residues in dermatan sulfate and heparan sulfate. Deficiency leads to lysosomal storage of these glycosaminoglycans, causing cellular dysfunction and tissue damage characteristic of Hunter syndrome.

Related Products

Product name Cat.No. Species Gene ID
IDS Knockout HEK293 Cell Line EDJ-KQ4973 Human 3423 Details Get a Quote
IDS Knockout HeLa Cell Line EDJ-KQ26635 Human 3423 Details Get a Quote
IDS Knockout A-549 Cell Line EDJ-KQ27855 Human 3423 Details Get a Quote
IDS Knockout HCT 116 Cell Line EDJ-KQ27856 Human 3423 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: